BHC


Why Does This Analyst Upgrade Bausch Health (BHC) Stock After Years of Distrust?

Bausch Health (BHC) is getting a bit of special treatment. Following a tough run of negative sentiment toward the company, Piper Jaffray analyst David Amsellem …

Is Bausch Health (BHC) Stock Under Stress For Good Reason?

Bausch Health Companies (BHC) has been in the spotlight recently for participating in a stalking horse bid to scoop up Synergy Pharmaceuticals (SGYP) …

Billionaire Izzy Englander Throws Chunk of Amarin (AMRN) Stock Out to Sea, But Reels in Bausch Health (BHC)

70-year-old Israel “Izzy” Englander, worth $6 billion to date, was born the same year as the state of Israel, and just one year …

Bausch Health (BHC) Stock Set to See Big Gains, Says Analyst

Analysts and investors have all expressed their thoughts on how things will pan out for Bausch Health (BHC) when taking on Synergy’s (SGYP) …

Patience Is Key When it Comes to Bausch Health (BHC) Stock, Says Analyst

Stifel analyst Annabel Samimy says when it comes to Bausch Health (BHC) stock, patience pays. Recall the company entered a “stalking horse” agreement …

Bausch Health (BHC) Stock: Steadfast Bear Raises a New Alarm

Is Bausch Health (BHC) making a mistake in acquiring certain assets of Synergy Pharmaceuticals (SGYP)? Maybe — at least if you ask Wells Fargo’s David Maris.

Bausch Health (BHC) (Tries) to Save Synergy Pharmaceuticals (SGYP) While It’s Down; Analyst Sees Upside for the Stock

Bausch Health Companies (BHC) announced today it will acquire some assets of Synergy Pharmaceuticals, which is being called the “stalking horse” agreement – …

Does Bausch Health (BHC) Stock Have a Clean and Bright Future? Not According to This Analyst

J.P Morgan’s Chris Schott recently met with Bausch Health (BHC) management to talk about the future of the pharmaceutical company.